Back to Journals » OncoTargets and Therapy » Volume 12

Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study

Total article views   HTML views PDF downloads Totals
7,944 Dovepress* 6,787+ 693 7,480
PubMed Central* 1,157 294 1,451
Totals 7,944 987 8,931
*Since 11 October 2019

View citations on PubMed Central and Google Scholar